N-Cbz-D-Serine

We are N-Cbz-D-Serine CAS:6081-61-4 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:N-Cbz-D-Serine
CAS.NO:6081-61-4
Synonyms:N-Cbz-D-Serine
(2R)-3-hydroxy-2-(phenylmethoxycarbonylamino)propanoic acid
Z-D-Ser-OH
N-Carbobenzoxy-DL-serine
Cbz-DL-serine
 
Physical and Chemical Properties:
Density 1.4±0.1 g/cm3
Boiling Point 487.5±45.0 °C at 760 mmHg
Melting Point 116-119ºC
Molecular Formula C11H13NO5
Molecular Weight 239.225
Flash Point 248.6±28.7 °C
Vapour Pressure 0.0±1.3 mmHg at 25°C
Index of Refraction 1.572
 
Specification:
Appearance:White powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Lacosamide(CAS:175481-36-4).

N-Cbz-D-Serine


Related News: We partner with life science companies of all sizes, drawing on over 20 years of industry experience.6-Oxo-1,6-dihydro-3-pyridazinecarboxamide At the same time, because the profits of a single variety of characteristic APIs do not have long-term growth, companies need more product reserves.N- (2-cloropirimidin-4-il) -N, 2,3-trimetil-2H-indazol-6-amina CAS:444731-75-3 At the same time, due to the increase in production costs and environmental protection cost pressures in Europe and the United States, as well as the improvement of process technology, production quality, and registration and certification capabilities of China’s bulk drug manufacturers, bulk drug companies have accelerated their transfer to China, and the bulk drug industry in China has produced Scale continues to increase.2,4-dicloropirido [2,3-d] pirimidina CAS:126728-20-9 The market for pharmaceutical intermediates is vast and is expected to usher in new growth. Compared with the pesticide intermediate business, the market space for pharmaceutical intermediates is larger and will be the focus of the company’s future development.ViiV, in which Pfizer and Shionogi have small stakes, said it received a so-called complete response letter (CRL) from the FDA in which the regulator questioned the treatment’s chemistry, manufacturing and controls process, but not its safety.

Related Products
Product Name
2-Fluoro-5-iodo-4-methylpyridine View Details
4-(Trifluoromethoxy)aniline View Details
1,1,1,2,2,4,5,5,5-nonafluoro-4-(trifluoromethyl)pentan-3-one Cas:756-13-8 View Details
1,1,1-Trifluoro-N-phenylmethanesulfonamide Cas:456-64-4 manufacturer CAS:1558-33-4 Wacker CMM1 manufacturer (3S,4S)-3-Hexyl-4-[(2S)-2-hydroxytridecyl]-2-oxetanone manufacturer Isododecane Cas:31807-55-3 manufacturer 2-chloro-5-(trifluoromethyl)benzene-1,3-diamine manufacturer